Alessandro Massano
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Advancing therapeutic frontiers: a pipeline of novel drugs for UC management.
Journal: Frontiers in gastroenterology (Lausanne, Switzerland)
Published: November 15, 2025
Relapse Rates and Predictors for Relapse in Ulcerative Colitis and Crohn's Disease Patients After Discontinuation of Vedolizumab or Ustekinumab: The REVEUS Study.
Journal: Journal of clinical medicine
Published: January 26, 2025
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.
Journal: Journal of clinical medicine
Published: January 23, 2024
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review.
Journal: Cancers
Published: June 25, 2023
Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study.
Journal: World journal of gastroenterology
Published: March 27, 2023
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis.
Journal: Viruses
Published: September 29, 2022
Periodontitis prevalence and severity in inflammatory bowel disease: A case-control study.
Journal: Journal of periodontology
Published: May 31, 2022
Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 24, 2021
Shared microbiological and immunological patterns in periodontitis and IBD: A scoping review.
Journal: Oral diseases
Published: January 14, 2021
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases.
Journal: Journal of clinical medicine
Published: February 24, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026